Dr. Bigelow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 North State Street
Department of Medicinedivision of Hematology
Jackson, MS 39216Phone+1 601-984-5615Fax+1 601-984-5689
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1983 - 1988
- University of Mississippi Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
- University of Mississippi Medical CenterResidency, Internal Medicine, 1979 - 1982
- University of Mississippi School of MedicineClass of 1979
Certifications & Licensure
- MS State Medical License 1979 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
Clinical Trials
- Effectiveness of Arginine as a Treatment for Sickle Cell Anemia Start of enrollment: 2004 Jun 01
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia Start of enrollment: 2007 Nov 15
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 160 citationsImprovements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso‐occlusive crises in patients with sickle cell disease: a phase III r...Kenneth I. Ataga, Marvin Reid, Samir K. Ballas, Zahida Yasin, Carolyn Bigelow
British Journal of Haematology. 2011-04-01 - 15 citationsProgression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation.Raleigh A. Bowden, Coombs Rw, Nikora Bh, Carolyn Bigelow, George E. Sale
The American Journal of Medicine. 1990-05-01 - 337 citationsThe risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-upMartin H. Steinberg, William F. McCarthy, Oswaldo Castro, Samir K. Ballas, F. Danny Armstrong
American Journal of Hematology. 2010-06-01
Journal Articles
- Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated DonorsParameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
Press Mentions
- Celebrating Its 30th Anniversary, BMT at UMMC Is Nationally RecognizedDecember 31st, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: